SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abuckatatime who wrote (2201)11/15/1998 10:53:00 AM
From: Abuckatatime   of 3414
 
Oscar Gruss & Son, Inc revises revenue and earnings estimates upward. In a Nov 5 report, analyst W.R.Prather M.D. comments on PM's stronger than expected Q2 showing and adjusts his projections accordingly. (!)
FY1999:
EPS: $0.67 from prior $0.66
Revenues: $99 million from $92 million
FY2000:
EPS: $0.90 from $0.81
Revenues: $116 million from $103 million
Continuing revenue gains from Liberty's expansion into the Type2 market as well as expanded market position of the AZO consumer line are cited as sources for PM's sustained growth.

OG sets a 12 month price target of $15. IMO, that is a conservative number, especially considering eps growth alone, which is projected to exceed 30%.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext